Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03679780 · ClinicalTrials.gov registry record · Phase 1
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
A Phase 1 study, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT03679780 is a Phase 1 study that has completed, run by The University of Texas at Arlington. The registered enrollment target is 19 participants.
The verdict
NCT03679780, a Phase 1 study, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
The goal of the study is to examine the possible mechanisms of impaired cutaneous microvascular function through local heating along with administration of vasoconstrictors.
Interventions
- DRUG Sodium Nitroprusside
- DRUG L-Arginine
- DRUG BQ-123
- DRUG BQ-788
- DRUG NG Nitro L Arginine Methyl Ester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2023-07-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03679780
The ClinicalTrials.gov registry entry for NCT03679780 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Sodium Nitroprusside is the first listed.
NCT03679780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03679780 about?
NCT03679780 is a clinical study titled "The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction". The goal of the study is to examine the possible mechanisms of impaired cutaneous microvascular function through local heating along with administration of vasoconstrictors.
What is the current status of trial NCT03679780?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2018-10-01. Estimated completion is 2023-07-26.
What interventions are being tested in trial NCT03679780?
The interventions under investigation include: Sodium Nitroprusside (DRUG), L-Arginine (DRUG), BQ-123 (DRUG), BQ-788 (DRUG), NG Nitro L Arginine Methyl Ester (DRUG).
Who is sponsoring clinical trial NCT03679780?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.